NEW YORK – Point-of-care diagnostic firm Jana Care announced on Monday that it has entered a collaboration agreement with Roche Diagnostics to develop blood tests for chronic kidney disease and heart failure.
Roche will distribute Jana Care's at-home testing platform, which allows patients to self-administer blood tests using fingerstick samples and clinicians to remotely review the tests, the companies said in a statement.
The addition of Roche as a partner "provides strong support to the company's momentum in bringing this groundbreaking technology to market," Jana Care CEO Anh Hoang-Lindsay said in a statement.
Financial and other terms of the agreement were not disclosed.
Boston-based Jana Care's initial focus is on testing for heart failure, chronic kidney disease, and diabetes, and the company has tests for potassium, serum creatinine, and N-terminal-prohormone natriuretic peptide in development.